Therapeutic Drug Monitoring of Ceftazidime-Avibactam Concentrations in Carbapenem-Resistant K. pneumoniae-Infected Patients With Different Kidney Statuses

• Autors principals: Xin-Qi Teng (Autor), Qiang Qu (Autor), Yue Luo (Autor), Wen-Ming Long (Autor), Hai-Hui Zhuang (Autor), Jiao-Hua Xu (Autor), Yu-Xin Wen (Autor), Hui-Lin Zhang (Autor), Jian Qu (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Aims: Carbapenem-resistant K. pneumoniae (CRKP) is the most common carbapenem-resistant Enterobacteriaceae with high mortality. Ceftazidime-avibactam (CAZ-AVI) has exhibited excellent in vitro activity in vivo against CRKP. However, the efficacy of CAZ-AVI in KPC-producing CRKP-infected patients wit...